INTELLIGENCE IN ACTION

AMA Recognizes the Need for Providers to More Easily Cancel Prescriptions

January 25, 2018

The American Medical Association (AMA) supports greater adoption of electronic prescription cancellation solutions, as resolved at its recent 2017 AMA Interim Meeting in Honolulu.

The nation’s largest association of physicians and medical students announced its new policy with a House of Delegates resolution stating its support for “the creation, standardization, and implementation of electronic prescription cancellation from all electronic medical record vendors and that these orders be accepted by pharmacies and pharmacy benefit managers.”

In arriving at the new policy, the AMA noted that reducing medication errors is a goal throughout all levels of medicine, and that the ability to cancel a prescription is available today but is woefully underutilized.

Surescripts applauds this latest AMA policy and is committed to helping healthcare professionals prevent errors and send higher quality prescriptions. In fact, Surescripts E-Prescribing includes the NCPDP SCRIPT CancelRx transaction. When a prescriber discontinues a medication in their electronic health record (EHR) system or wants to correct a prescription error, CancelRx sends an electronic message to the pharmacy. Prescribers can also enter notes within the message to indicate the updated prescription or discontinued drug, giving the pharmacist more information in order to provide the best care to the patient. This information empowers the pharmacist to safely and accurately fill the prescription and deliver the best possible patient care at the pharmacy.

For far too long, the full potential of CancelRx has gone unrealized. So, as part of our continuous efforts to perfect e-prescribing, Surescripts has let the industry in promoting this critical functionality. 

Achieving this goal requires strong cross-market partnerships to unite disparate data from across healthcare. So in 2015, we convened more than 200 industry leaders to launch the Critical Performance Improvement program. Together we‘re working towards more successfully delivering accurate patient and clinical information in the form of error-free prescriptions. As a result, CancelRx use skyrocketed in 2017, increasing by almost 200 percent over 2016.

Increased CancelRx adoption, plus our other quality improvement measures, means Surescripts is on track to eliminate 50 million instances per month where a pharmacist has to seek clarification on prescriber intent­­—usually by leaving their normal workflow—to accurately fill a prescription. If you think of each of those 50 million potential instances in terms of real patients who depend on getting the right medication, the power of CancelRx to positively impact healthcare quality, safety and cost becomes crystal clear.

In addition to the valuable benefits of CancelRx, the Surescripts Network Alliance is increasing safety, accuracy and efficiency by offering expanded capabilities such as Electronic Prescribing of Controlled Substances. We are reaching new markets like Long-Term Care and automating the prescribing process for specialty medications. And we’re also leveraging the combined benefit of safe and seamless prescribing with electronic prior authorization and price transparency at the point of care, thereby transforming the prescription decision process and promoting medication adherence.

All of this work to enhance prescribing and inform care decisions ensures that prescribers and pharmacists have a streamlined and reliable workflow, so that they can stay off the phone and on the front lines with their patients, where they’re needed most.

Related Articles

January 10, 2020

AHIP Puts Surescripts Electronic Prior Authorization Tool to The Test

What if I told you Surescripts has a solution to one of the top workflow challenges faced by physicians today?

Manual prior authorization has been cited by doctors as one of their biggest frustrations, costing them valuable time and money and, more importantly, increasing medication non-adherence. Yet 46% of requests are still submitted by fax and 60% require a phone call.

Read more...
December 18, 2019

The Final Countdown: Healthcare is Poised for NCPDP SCRIPT Version 2017071

In healthcare, change has always been the name of the game. Over the years, some of these changes have felt imposed upon our industry without consensus or clear logic. Yet other requirements are designed from the ground up to make things better for patients. The new NCPDP e-prescribing standard is one such requirement. Read more...
December 11, 2019

New Perspectives on the New SCRIPT Standard: What Pharmacies Need to Know

You’ve heard it many times before and you’ll likely hear it many more times: The Centers for Medicare and Medicaid Services' adoption of the National Council for Prescription Drug Programs (NCPDP) SCRIPT standard v2017071 is set for January 1, 2020.

Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX